These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36871242)

  • 1. Extremely high unbound flucloxacillin concentrations in a patient with acute septic renal failure during continuous venovenous hemofiltration: Therapeutic drug monitoring to optimize treatment.
    Appelman EM; Wammes van-der-Heijden EA; Meenks SD; Janssen PKC; le Noble JLML
    Int J Clin Pharmacol Ther; 2023 Mar; ():. PubMed ID: 36871242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin.
    Meyer B; Ahmed el Gendy S; Delle Karth G; Locker GJ; Heinz G; Jaeger W; Thalhammer F
    Kidney Blood Press Res; 2003; 26(2):135-40. PubMed ID: 12771540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-therapeutic trimethoprim and sulfamethoxazole plasma concentrations during continuous venovenous hemofiltration in a patient with COVID-19 and pulmonary
    le Noble JLML; Foudraine N; van der Elst KCM; Bouwman S
    Int J Clin Pharmacol Ther; 2023 Nov; 61(11):525-530. PubMed ID: 37489071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin removal by continuous venovenous hemofiltration.
    Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
    Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs.
    Moser S; Rehm S; Guertler N; Hinic V; Dräger S; Bassetti S; Rentsch KM; Sendi P; Osthoff M
    J Antimicrob Chemother; 2021 Jun; 76(7):1845-1854. PubMed ID: 33860325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.
    Yu Y; Bai M; Wei Z; Zhao L; Li Y; Ma F; Sun S
    Ren Fail; 2020 Nov; 42(1):748-758. PubMed ID: 32718221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different modalities of continuous renal replacement therapy with regional sodium citrate anticoagulation in paediatric patients.
    He J; Xiao Z; Zhou X; Cao J; Kang X; Zhang X
    Int J Artif Organs; 2022 Dec; 45(12):997-1005. PubMed ID: 35903018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
    Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
    Wilkes S; van Berlo I; Ten Oever J; Jansman F; Ter Heine R
    Int J Antimicrob Agents; 2019 Mar; 53(3):310-317. PubMed ID: 30472288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
    Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
    Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    Yu Y; Bai M; Ma F; Zhang W; Li Y; Zhao L; Li L; Zhou M; Li L; Sun S
    PLoS One; 2020; 15(5):e0232516. PubMed ID: 32369523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.
    Bouman CS; van Kan HJ; Koopmans RP; Korevaar JC; Schultz MJ; Vroom MB
    Intensive Care Med; 2006 Dec; 32(12):2013-9. PubMed ID: 17043848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.
    Heering P; Morgera S; Schmitz FJ; Schmitz G; Willers R; Schultheiss HP; Strauer BE; Grabensee B
    Intensive Care Med; 1997 Mar; 23(3):288-96. PubMed ID: 9083231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplified regional citrate anticoagulation using a calcium-containing replacement solution for continuous venovenous hemofiltration.
    Zhang L; Liao Y; Xiang J; Qin W; Wu X; Tang Y; Yang Y; Chen Z; Fu P
    J Artif Organs; 2013 Jun; 16(2):185-92. PubMed ID: 23271571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of continuous renal replacement therapy on the plasma concentration of imipenem in severe infection patients with acute renal injury].
    Yu B; Liu L; Xing D; Zhao C; Hu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):359-65. PubMed ID: 26003640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients.
    Campbell PO; Chin PKL; Dalton SC; Metcalf SCL; Douglas NM; Chambers ST
    Int J Antimicrob Agents; 2023 Jan; 61(1):106695. PubMed ID: 36464153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied.
    Schilder L; Nurmohamed SA; ter Wee PM; Paauw NJ; Girbes AR; Beishuizen A; Beelen RH; Groeneveld AB
    Crit Care; 2014 Apr; 18(2):R78. PubMed ID: 24755339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.